SCHEMBL25798804

SCHEMBL25798804

COc1ccccc1[P@@](=O)(c1ccccc1)c1cccc(C)c1

nearest known ligand 0.76

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
KMT2A Q03164 5/20 0.51
MEN1 O00255 4/20 0.49
HTT P42858 2/20 0.47
POLB P06746 2/20 0.47
ALDH1A1 P00352 2/20 0.47
L3MBTL1 Q9Y468 2/20 0.42
NPC1 O15118 2/20 0.42
RAB9A P51151 2/20 0.42
MAPT P10636 2/20 0.40
NPSR1 Q6W5P4 2/20 0.40
TDP1 Q9NUW8 1/20 0.40
KDM4E B2RXH2 1/20 0.40
KCNK3 O14649 1/20 0.39
KCNK9 Q9NPC2 1/20 0.39
HPGD P15428 3/20 0.38
CYP1A2 P05177 1/20 0.38
CYP3A4 P08684 1/20 0.38
CYP2C9 P11712 1/20 0.38
CYP2C19 P33261 1/20 0.38
TP53 P04637 1/20 0.37

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL25798801 1.00 KMT2A (0.51) KMT2AMEN1HTTPOLBALDH1A1
SCHEMBL25797401 1.00 KMT2A (0.51) KMT2AMEN1HTTPOLBALDH1A1
SCHEMBL14259711 0.87 KMT2A (0.60) KMT2AMEN1HTTPOLBALDH1A1
SCHEMBL25798784 0.86 KMT2A (0.53) KMT2AMEN1HTTPOLBALDH1A1
SCHEMBL25798781 0.86 KMT2A (0.53) KMT2AMEN1HTTPOLBALDH1A1
SCHEMBL23658969 0.86 KMT2A (0.53) KMT2AMEN1HTTPOLBALDH1A1
SCHEMBL23658963 0.85 KMT2A (0.51) KMT2AMEN1HTTPOLBALDH1A1
SCHEMBL18486442 0.84 KMT2A (0.60) KMT2AMEN1HTTPOLBALDH1A1
SCHEMBL26087274 0.83 KMT2A (0.51) KMT2AMEN1HTTPOLBALDH1A1
SCHEMBL25797628 0.81 NPSR1 (0.44) KMT2AMEN1HTTPOLBALDH1A1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20230212204-A1 REAGENTS AND THEIR USE FOR MODULAR ENANTIODIVERGENT SYNTHESIS OF C-P BONDS THE SCRIPPS RESEARCH INSTITUTE 2023-07-06 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20230212204-A1 REAGENTS AND THEIR USE FOR MODULAR ENANTIODIVERGENT SYNTHESIS OF C-P BONDS PNKP, POLL, RNGTT KMT2A 2666/4885MEN1 2014/4885HTT 3532/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.